Actively Recruiting
The Lymphocytic Infiltrate of Lung Tumors.
Led by Scientific Institute San Raffaele · Updated on 2024-11-29
70
Participants Needed
1
Research Sites
262 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is configured as a monocentric observational transversal biological study. The main objective of the study is the reconstruction of the molecular organization of tumors of the thoracic cavity, in particular non-small cell lung cancer (NSCLC). The study involves the collection of clinical data and biological material (blood and tumor tissue) from 70 subjects diagnosed with thoracic tumors.
CONDITIONS
Official Title
The Lymphocytic Infiltrate of Lung Tumors.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to provide informed consent
- Men and women over the age of 18
- Patients candidates for surgical treatment diagnosed with thoracic tumors
You will not qualify if you...
- Previous chemotherapy for any cancer within the last 6 months
- Pregnant and/or breastfeeding women
- Immunosuppressive state or ongoing immunosuppressive/immunomodulatory treatments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Scientific Institute Ospedale San Raffaele
Milan, Italy, 20132
Actively Recruiting
Research Team
P
Pierluigi Novellis, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here